DK1864131T3 - Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf - Google Patents

Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf

Info

Publication number
DK1864131T3
DK1864131T3 DK06707378.3T DK06707378T DK1864131T3 DK 1864131 T3 DK1864131 T3 DK 1864131T3 DK 06707378 T DK06707378 T DK 06707378T DK 1864131 T3 DK1864131 T3 DK 1864131T3
Authority
DK
Denmark
Prior art keywords
rcc356
protein coupled
coupled receptor
natural ligand
applications
Prior art date
Application number
DK06707378.3T
Other languages
English (en)
Inventor
Frederic Sallman
Alex Veithen
Magali Philippeau
Original Assignee
Chemcom Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemcom Sa filed Critical Chemcom Sa
Application granted granted Critical
Publication of DK1864131T3 publication Critical patent/DK1864131T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06707378.3T 2005-03-03 2006-03-02 Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf DK1864131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05447046 2005-03-03
PCT/EP2006/001904 WO2006094704A2 (en) 2005-03-03 2006-03-02 Natural ligand of g protein coupled receptor rcc356 and uses thereof

Publications (1)

Publication Number Publication Date
DK1864131T3 true DK1864131T3 (da) 2011-10-31

Family

ID=35344663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06707378.3T DK1864131T3 (da) 2005-03-03 2006-03-02 Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf

Country Status (9)

Country Link
US (1) US8008023B2 (da)
EP (1) EP1864131B1 (da)
JP (1) JP5307404B2 (da)
AT (1) ATE526585T1 (da)
AU (1) AU2006222265B2 (da)
CA (1) CA2597255C (da)
DK (1) DK1864131T3 (da)
ES (1) ES2373913T3 (da)
WO (1) WO2006094704A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007081716A2 (en) * 2006-01-04 2007-07-19 Stanford University Self-illuminating quantum dot systems and methods of use thereof
WO2008123266A1 (ja) * 2007-03-19 2008-10-16 Reverse Proteomics Research Institute Co., Ltd. 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
GB201020133D0 (en) * 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
US8637259B1 (en) * 2011-02-09 2014-01-28 Chemcom S.A. Methods of identifying modulators of olfactory receptors involved in the perception of sweat carboxylic acids
ES2746929T3 (es) * 2011-04-07 2020-03-09 Scripps Research Inst Cribado de alto rendimiento para compuestos que modulan los niveles de macromoléculas celulares
WO2013034666A2 (en) * 2011-09-08 2013-03-14 Chemcom S.A. Novel pheromonal receptor of spodoptera littoralis (lepidoptera, noctuidae) and identification of natural ligand of said receptor and uses thereof
JP5948139B2 (ja) * 2012-05-11 2016-07-06 ヒノキ新薬株式会社 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
PL3004157T3 (pl) 2013-05-31 2018-03-30 Chemcom S.A. Receptory węchowe zaangażowane w odbieranie kwasów karboksylowych z potu oraz ich zastosowanie
US10429300B2 (en) 2015-01-26 2019-10-01 The Johns Hopkins University Surface plasmon resonance approach to monitor protein-ligand interactions
JP6371336B2 (ja) 2015-06-17 2018-08-08 花王株式会社 ポリスルフィド化合物の臭いの抑制剤
JP6122181B2 (ja) 2015-06-17 2017-04-26 花王株式会社 スルフィド化合物の臭いの抑制剤の評価又は選択方法
EP3670656A4 (en) * 2017-08-17 2021-10-13 Komi Hakko Corporation ODOR QUANTIFICATION PROCESS, CELLS USED IN THIS PROCESS AND PROCESS FOR THE PRODUCTION OF SUCH CELLS
US11867685B2 (en) 2017-12-05 2024-01-09 Chemcom S.A. Olfactory receptor involved in the perception of musk fragrance and the use thereof
CN112143547B (zh) * 2020-09-22 2022-07-15 上海桉欣新能源科技有限公司 一种制冷压缩机用润滑油及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1048494B (en) * 1999-10-05 2009-06-12 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
AU2002220265A1 (en) * 2000-11-03 2002-05-15 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20030096299A1 (en) * 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
JP4360915B2 (ja) * 2002-01-07 2009-11-11 ユーロスクリーン・ソシエテ・アノニム Ｇタンパク質共役受容体ｇｐｒ４３のリガンドおよびその使用

Also Published As

Publication number Publication date
US20090264526A1 (en) 2009-10-22
CA2597255C (en) 2014-05-27
AU2006222265B2 (en) 2012-07-05
WO2006094704A2 (en) 2006-09-14
CA2597255A1 (en) 2006-09-14
JP2008538278A (ja) 2008-10-23
EP1864131B1 (en) 2011-09-28
US8008023B2 (en) 2011-08-30
ES2373913T3 (es) 2012-02-10
EP1864131A2 (en) 2007-12-12
JP5307404B2 (ja) 2013-10-02
WO2006094704A3 (en) 2006-11-09
AU2006222265A1 (en) 2006-09-14
ATE526585T1 (de) 2011-10-15

Similar Documents

Publication Publication Date Title
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
DK1864131T3 (da) Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
ATE485359T1 (de) Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
DE602005002836D1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
CY1110579T1 (el) Η λειτουργια ενος υποδοχεα απτοσφαιρινης-αιμοσφαιρινης και οι χρησεις αυτου
EP1853313A4 (en) HUMANIZED L243 ANTIBODIES
WO2011069156A3 (en) Compositions and methods for enhancing odorant receptor activity
DK1791571T3 (da) Radiofluorinerede peptider
ATE479699T1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
MX2007015931A (es) Receptores de sabor dulce-umami y umami-dulce humanos quimericos.
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
EA200800301A1 (ru) Протеины, связывающие il-6
NO20074277L (no) Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer
ATE437370T1 (de) Pharmakodynamische tests mit durchflusszytometrie
DE60324331D1 (de) Millisekunden-aktivationsschalter für 7-transmembran-proteine
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
EA200702193A1 (ru) Гликозилирование белков
CY1110891T1 (el) Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
CY1112488T1 (el) Μεθοδος για τον ποσοτικο προσδιορισμο των πολοξαμερων